RUSH, NY – May 14, 2019 – iuvo BioScience is pleased to announce the addition of Joe Grappin as Manager, Business Development, expanding their commercial footprint for Medical Device Testing services.
“We’re very pleased to have Mr. Grappin join the iuvo family, and bring his tremendous experience in technical and business development roles to our team,” said iuvo CEO Ben Burton. “Joe’s presence and credibility in the medical device testing industry will be a great addition as we continue to drive significant organic growth in this important business segment.”
Mr. Grappin has a wealth of experience and most recently served as Account Executive for EAG Labs – Eurofins Materials Science where he developed and implemented sales strategies for medical device and in vitro diagnostics markets. He also worked at NAMSA for 11 years in various roles including Account Executive responsible for the growth of sales in the Chemistry, Microbiology, Toxicology and Validation testing offerings and previously as Director of Analytical Services.
Joe holds a BS in Chemistry and an MS in Polymer Technology from Eastern Michigan University. When not engaging with clients at their sites, he will work from an office in Irvine, CA.
"I'm very excited about joining iuvo BioScience. It is great to be part of a company with such strong vision and a dynamic future filled with growth and opportunity. I believe with my skills and talents, I will be able to convey this excitement to our clients and show the value that iuvo delivers. This will help ensure iuvo's success in continuing to meet and often exceed our business objectives," said Mr. Grappin.
About iuvo BioScience
iuvo BioScience is a Partner Research Organization (PRO) serving the medical device and pharmaceutical industries. The Company provides contract laboratory services, as well as technical and preclinical consulting from its location in Western New York. The Company has extensive expertise in toxicology, analytical chemistry and microbiology. More information on the Company’s services and capabilities is available on the Company’s website at www.iuvobioscience.com.
Oculos, an iuvo BioScience company, is a truly integrated, full-service Partner Research Organization (PRO) with focused expertise in developing ophthalmological products, from pre-clinical testing, CMC / technical services and clinical ophthalmological research. Oculos and iuvo together provide complete support from the pre-clinical development stage through clinical trial management for ocular products. More information on Oculos' services and capabilities are available at www.oculoscr.com.